Cytoplasmic dynein: A key player in neurodegenerative and neurodevelopmental diseases

Science China Life Sciences

Volumn 57, Issue 4, 2014, Pages 372-377

  Chen, Xiang Jun ^a   Xu, Huan ^a   Cooper, Helen M ^c   Liu, Yaobo ^b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

dynein; neurodegenerative diseases; neurodevelopmental diseases; pathogenesis; retrograde transport

Indexed keywords

MUS;

DYNEIN ADENOSINE TRIPHOSPHATASE;

ALZHEIMER DISEASE; ANIMAL; CENTROSOME; CHEMISTRY; CYTOPLASM; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; METABOLISM; MICROTUBULE; MOUSE; MUTATION; NERVE FIBER TRANSPORT; PARKINSON DISEASE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ALZHEIMER DISEASE; ANIMALS; AXONAL TRANSPORT; BIOLOGICAL TRANSPORT; CENTROSOME; CHARCOT-MARIE-TOOTH DISEASE; CYTOPLASM; DEVELOPMENTAL DISABILITIES; DYNEINS; HUMANS; HUNTINGTON DISEASE; MICE; MICROTUBULES; MUTATION; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 84899932523     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4639-9     Document Type: Review

References (58)

1. Paschal BM, Shpetner HS, Vallee RB. MAP 1C is a microtubule-activated ATPase which translocates microtubules in vitro and has dynein-like properties. J Cell Biol, 1987, 105: 1273-1282.
2. Allan VJ. Cytoplasmic dynein. Biochem Soc Trans, 2011, 39: 1169-1178.
3. Pfister KK, Shah PR, Hummerich H, Russ A, Cotton J, Annuar AA, King SM, Fisher EM. Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet, 2006, 2: e1.
4. Pfister KK. Dynein cargo gets its groove back. Structure, 2005, 13: 172-173.
5. Moughamian AJ, Holzbaur EL. Dynactin is required for transport initiation from the distal axon. Neuron, 2012, 74: 331-343.
6. Vaughan KT, Vallee RB. Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued. J Cell Biol, 1995, 131: 1507-1516.
7. Kobayashi T, Shiroguchi K, Edamatsu M, Toyoshima YY. Microtubule-binding properties of dynactin p150 expedient for dynein motility. Biochem Biophys Res Commun, 2006, 340: 23-28.
8. Culver-Hanlon TL, Lex SA, Stephens AD, Quintyne NJ, King SJ. A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules. Nat Cell Biol, 2006, 8: 264-270.
9. Heald R, Tournebize R, Habermann A, Karsenti E, Hyman A. Spindle assembly in Xenopus egg extracts: respective roles of centrosomes and microtubule self-organization. J Cell Biol, 1997, 138: 615-628.
10. Karki S, Holzbaur EL. Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr Opin Cell Biol, 1999, 11: 45-53.
11. Vallee RB, Williams JC, Varma D, Barnhart LE. Dynein: an ancient motor protein involved in multiple modes of transport. J Neurobiol, 2004, 58: 189-200.
12. Kardon JR, Vale RD. Regulators of the cytoplasmic dynein motor. Nat Rev Mol Cell Biol, 2009, 10: 854-865.
13. McKenney RJ, Vershinin M, Kunwar A, Vallee RB, Gross SP. LIS1 and NudE induce a persistent dynein force-producing state. Cell, 2010, 141: 304-314.
14. Chevalier-Larsen E, Holzbaur EL. Axonal transport and neurodegenerative disease. Biochim Biophys Acta, 2006, 1762: 1094-1108.
15. Soo KY, Farg M, Atkin JD. Molecular motor proteins and amyotrophic lateral sclerosis. Int J Mol Sci, 2011, 12: 9057-9082.
16. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 364: 362.
17. Brown RJ. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell, 1995, 80: 687-692.
18. Turner BJ, Lopes EC, Cheema SS. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts. J Cell Biochem, 2004, 91: 1074-1084.
19. Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, Fisher EM, Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol, 2005, 169: 561-567.
20. Teuchert M, Fischer D, Schwalenstoecker B, Habisch HJ, Bockers TM, Ludolph AC. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp Neurol, 2006, 198: 271-274.
21. Zhang F, Strom AL, Fukada K, Lee S, Hayward LJ, Zhu H. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem, 2007, 282: 16691-16699.
22. El-Kadi AM, Soura V, Hafezparast M. Defective axonal transport in motor neuron disease. J Neurosci Res, 2007, 85: 2557-2566.
23. Banks GT, Fisher EM. Cytoplasmic dynein could be key to understanding neurodegeneration. Genome Biol, 2008, 9: 214.
24. Chen XJ, Levedakou EN, Millen KJ, Wollmann RL, Soliven B, Popko B. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J Neurosci, 2007, 27: 14515-14524.
25. Vande VC, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci USA, 2008, 105: 4022-4027.
26. Strom AL, Gal J, Shi P, Kasarskis EJ, Hayward LJ, Zhu H. Retrograde axonal transport and motor neuron disease. J Neurochem, 2008, 106: 495-505.
27. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet, 1974, 6: 98-118.
28. Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med, 2006, 8: 3-22.
29. Szigeti K, Lupski JR. Charcot-Marie-Tooth disease. Eur J Hum Genet, 2009, 17: 703-710.
30. Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, Williams M, King C, Greenhalgh L, Newbury-Ecob R, Ellard S. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet, 2011, 89: 308-312.
31. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, FitzPatrick D, Schmedding E, De Vriendt E, Jacobs A, van Gerwen V, Wagner K, Hartung HP, Timmerman V. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet, 2003, 72: 722-727.
32. Jordens I, Fernandez-Borja M, Marsman M, Dusseljee S, Janssen L, Calafat J, Janssen H, Wubbolts R, Neefjes J. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol, 2001, 11: 1680-1685.
33. Perez-Olle R, Jones ST, Liem RK. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum Mol Genet, 2004, 13: 2207-2220.
34. Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci, 2010, 30: 4232-4240.
35. Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, Anderton BH, Leigh PN, Shaw CE, Miller CC. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet, 2002, 11: 2837-2844.
36. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, Morgan PJ, Oozageer R, Priestley JV, Averill S, King VR, Ball S, Peters J, Toda T, Yamamoto A, Hiraoka Y, Augustin M, Korthaus D, Wattler S, Wabnitz P, Dickneite C, Lampel S, Boehme F, Peraus G, Popp A, Rudelius M, Schlegel J, Fuchs H, Hrabe DAM, Schiavo G, Shima DT, Russ AP, Stumm G, Martin JE, Fisher EM. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science, 2003, 300: 808-812.
37. Wiggins LM, Kuta A, Stevens JC, Fisher EM, von Bartheld CS. A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons. J Comp Neurol, 2012, 520: 2757-2773.
38. Zhang Z, Casey DM, Julien JP, Xu Z. Normal dendritic arborization in spinal motoneurons requires neurofilament subunit L. J Comp Neurol, 2002, 450: 144-152.
39. Matsuo S, Ichikawa H, Silos-Santiago I, Arends JJ, Henderson TA, Kiyomiya K, Kurebe M, Jacquin MF. Proprioceptive afferents survive in the masseter muscle of trkC knockout mice. Neuroscience, 2000, 95: 209-216.
40. Ding J, Allen E, Wang W, Valle A, Wu C, Nardine T, Cui B, Yi J, Taylor A, Jeon NL, Chu S, So Y, Vogel H, Tolwani R, Mobley W, Yang Y. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet, 2006, 15: 1451-463.
41. Lopez-de-Ipina K, Alonso JB, Travieso CM, Sole-Casals J, Egiraun H, Faundez-Zanuy M, Ezeiza A, Barroso N, Ecay-Torres M, Martinez-Lage P, Martinez DLU. On the selection of non-invasive methods based on speech analysis oriented to automatic Alzheimer disease diagnosis. Sensors (Basel), 2013, 13: 6730-6745.
42. Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology, 2004, 62: 1984-1989.
43. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci, 2003, 23: 4499-4508.
44. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, LaDu M, Busciglio J, Brady S. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA, 2009, 106: 5907-5912.
45. Eschbach J, Dupuis L. Cytoplasmic dynein in neurodegeneration. Pharmacol Ther, 2011, 130: 348-363.
46. Kimura N, Imamura O, Ono F, Terao K. Aging attenuates dynactindynein interaction: down-regulation of dynein causes accumulation of endogenous tau and amyloid precursor protein in human neuroblastoma cells. J Neurosci Res, 2007, 85: 2909-2916.
47. Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, Ceresa BP, Nixon RA, Cataldo AM. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular betacleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem, 2003, 278: 31261-31268.
48. Zhao H, Chang R, Che H, Wang J, Yang L, Fang W, Xia Y, Li N, Ma Q, Wang X. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse. Neurosci Lett, 2013, 551: 12-16.
49. Geekiyanage H, Upadhye A, Chan C. Inhibition of serine palmitoyltransferase reduces Abeta and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease. Neurobiol Aging, 2013, 34: 2037-2051.
50. Niewiadomska G, Baksalerska-Pazera M, Riedel G. Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann N Y Acad Sci, 2005, 1048: 287-295.
51. Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet, 2001, 10: 1243-1254.
52. Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilarino-Guell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK. DCTN1 mutations in Perry syndrome. Nat Genet, 2009, 41: 163-165.
53. McKenney RJ, Vershinin M, Kunwar A, Vallee RB, Gross SP. LIS1 and NudE induce a persistent dynein force-producing state. Cell, 2010, 141: 304-314.
54. Grabham PW, Seale GE, Bennecib M, Goldberg DJ, Vallee RB. Cytoplasmic dynein and LIS1 are required for microtubule advance during growth cone remodeling and fast axonal outgrowth. J Neurosci, 2007, 27: 5823-5834.
55. Sasaki S, Shionoya A, Ishida M, Gambello MJ, Yingling J, Wynshaw-Boris A, Hirotsune S. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron, 2000, 28: 681-696.
56. Shu T, Ayala R, Nguyen MD, Xie Z, Gleeson JG, Tsai LH. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron, 2004, 44: 263-277.
57. Shu T, Ayala R, Nguyen MD, Xie Z, Gleeson JG, Tsai LH. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron, 2004, 44: 263-277.
58. Moon HM, Wynshaw-Boris A. Cytoskeleton in action: lissencephaly, a neuronal migration disorder. Wiley Interdiscip Rev Dev Biol, 2013, 2: 229-245.